Follow The Filings

CNXU Conexeu Sciences

Conexeu Sciences earnings company data as of 7:59 PM ET 10/5

  • 0 of 1 EPS beats

History

1 period, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 14 Sep EPS -0.10 -0.29 Miss
Rev — — —

Insider trades

Open-market buys and sales by CNXU's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CNXU insider trades
  • $1.3M bought by 2 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Lynn Sebastian Purcell Director
    Buy
    $500K 166,666 shares at $3.00 +5.6% to stake
    Traded Oct 15 Filed Oct 19
    ↗
  2. Lynn Sebastian Purcell Director
    Buy
    $162K 202,500 shares at $0.8000 +8% to stake
    Traded Jun 18 Filed Jun 23
    ↗
  3. Lynn Sebastian Purcell Director
    Buy
    $338K 422,500 shares at $0.8000 +20% to stake
    Traded May 12 Filed May 14
    ↗

Also filed in the last 12 months, not counted as buying or selling: 6 option exercises and 1 stock grant.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
424B3 FORM 424B3 Filing Doc
8-K 3.02,9.01 Filing Doc
SCHEDULE 13D/A — Filing Doc
424B3 FORM 424B3 Filing Doc
10-Q FORM 10-Q Filing Doc
8-K 3.02,9.01 Filing Doc
424B3 FORM 424B3 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13D — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 7.01,9.01 Filing Doc
424B3 FORM 424B3 Filing Doc
10-Q FORM 10-Q Filing Doc
8-K 3.02,9.01 Filing Doc
424B3 FORM 424B3 Filing Doc
8-K 3.02,5.03,9.01 Filing Doc
424B3 FORM 424B3 Filing Doc
424B4 FORM 424B4 Filing Doc
S-1/A FORM S-1/A Filing Doc

Source: SEC EDGAR submissions, updated 3 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.